Vimarsana
Biggest News Aggregation in the World

Page 4 - Nasdaq Caba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Caba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Caba Today - Breaking & Trending Today

Cabaletta Bio (NASDAQ:CABA) Stock Price Down 4.2% - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Stock Price Down 4.2%

Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) traded down 4.2% during trading on Monday . The company traded as low as $17.17 and last traded at $17.20. 167,698 shares changed hands during trading, a decline of 70% from the average session volume of 560,050 shares. The stock had previously closed at $17.96. […]

Cabaletta Bio (NASDAQ:CABA) Price Target Raised to $50.00 - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Price Target Raised to $50.00

Cabaletta Bio (NASDAQ:CABA – Free Report) had its price target raised by Cantor Fitzgerald from $40.00 to $50.00 in a research report sent to investors on Wednesday, Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock. Several other equities research analysts also recently weighed in on CABA. Stifel Nicolaus started coverage on […]

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Rating of "Buy" from Brokerages - Vimarsana News

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Rating of "Buy" from Brokerages

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned an average recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued a report on the stock in the […]

Source: wkrb13.com
Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $21.00 - Vimarsana News

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $21.00

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have updated their coverage on the stock in the […]

Source: wkrb13.com
Cabaletta Bio (NASDAQ:CABA) Stock Rating Reaffirmed by HC Wainwright - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Stock Rating Reaffirmed by HC Wainwright

Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $17.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 9.32% from the stock’s current price. A number of […]